BAMTIVTY

Serial Number 98478133
606

Registration Progress

Application Filed
Apr 1, 2024
Under Examination
Feb 4, 2025
Approved for Publication
Dec 10, 2024
Published for Opposition
Dec 10, 2024
Registered

Trademark Image

BAMTIVTY

Basic Information

Serial Number
98478133
Filing Date
April 1, 2024
Published for Opposition
December 10, 2024
Abandonment Date
September 8, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Sep 8, 2025
Classes
005

Rights Holder

Pfizer Inc.

03
Address
66 Hudson Boulevard East
New York, NY 10001-2192

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Pfizer Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Andrea Christensen

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

10 events
Date Code Type Description Documents
Sep 8, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Sep 8, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 4, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 10, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 10, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 4, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 14, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 11, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 4, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 1, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of hemophilia.

Classification

International Classes
005